Delivery Order SPE2DB22D3501-SPE2DB26FTF86
Award Date 10/24/25
Potential Completion Date 10/27/25
Potential Value $2.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,448 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Mitomycin 40 mg vials, with completion targeted for September 16, 2025. This firm fixed-price contract is a non-set-aside award executed as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999 through December 2026. The pharmaceutical will be...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,201.40 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 20 mg vials of the cancer drug mitomycin. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive...
- The Defense Logistics Agency awarded a $2,550.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dactinomycin 500 microgram vials, with an ultimate completion date of September 18, 2025. This non-set-aside delivery order represents a competitive award to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for military and veteran...
- The Defense Logistics Agency awarded a $2,896.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mycophenolate 500 mg vials, with an ultimate completion date of September 12, 2025. This competitively awarded contract, issued without set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026....
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $20,642.51 to AmerisourceBergen Drug Corp on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a $1,346.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mycophenolate 500 mg vials. This contract, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a non-competitive set-aside delivery order executed through the company's existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $40,227 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This is a firm fixed-price, non-set-aside delivery order issued under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a comprehensive...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,004.85 to AmerisourceBergen Drug Corp on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor under its broader contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $41,480.40 to AmerisourceBergen Drug Corp on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carries no set-aside designation...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $27,081.44 for Mylotarg 4.5 mg vials under a Defense Logistics Agency contract with the Medical Supply Chain. The award, made on September 8, 2025, with an ultimate completion date of September 29, 2025, represents a firm fixed price, competitively awarded delivery against an existing contract vehicle. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order does not...